From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Kijun Yoon, who discussed the latest updates in Zika research, including his work on a Zika virus protein that may cause microcephaly.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
Take a look at our infographic below to learn more about this emerging virus and find out key facts about Zika infection.
18 months on from the WHO’s declaration of a Public Health Emergency, we provide an update on Zika, including a research round-up and vaccine pipelines.
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Is a Zika vaccine imminent? Martha Powell provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
How researchers and physicians have risen to the Zika challenge a short year and half after the WHO declared a public health emergency.
Research presented at ASM Microbe has reported a Zika vaccine based on the NS1 protein can induce protective immunity in mouse models after a single dose.
A new first-of-its-kind study will assess Zika virus as a tool to target glioblastomas, one of the most challenging cancers to treat.